In general, PSA screening refers to a structured program or policy where men, typically aged 50 to 75, are invited to participate in a PSA test and possibly a digital rectal examination as part of a surveillance approach to identify prostate cancer [20]. This evidence concerns the gene KLK3 and prostate cancer.